Ulcerative Colitis
Ulcerative Colitis (UC) is a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the colon, leading to symptoms such as abdominal pain, diarrhea, and rectal bleeding.
Ulcerative Colitis: SAR442970 Study
We are investigating how effective different doses of SAR442970 are for adults with moderate to severe ulcerative colitis. The study aims to see if it can help improve symptoms and overall quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have ulcerative colitis (UC)?
- Are you currently pregnant or breastfeeding?
- Are you taking corticosteroids like prednisone or budesonide?
- Have you had any major surgery in the past 4 weeks?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Sar442970
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Vojenska Nemocnice Brno
Internal department
Brno, Czechia
Nemocnice Slany
Gastroenterology department
Slaný, Czechia
Centre Hospitalier Universitaire De Lille
Adult gastroenterology- Digestive System Diseases
Loos, France
Sponsor: Sanofi-Aventis Recherche & Developpement
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.